Accessibility Menu
 
Bio-Path logo

Bio-Path

(OTC) BPTH

Current Price$0.04
Market Cap$383,000
Since IPO (2008)-100%
5 YearN/A
1 Year-77%
1 Month-32%

Bio-Path Financials at a Glance

Market Cap

$383,000

Revenue (TTM)

$0.00

Net Income (TTM)

$6.09M

EPS (TTM)

$-0.72

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.04

Volume

102,811

Open

$0.04

Previous Close

$0.04

Daily Range

$0.03 - $0.04

52-Week Range

$0.01 - $0.23

BPTH News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bio-Path

Industry

Biotechnology

Employees

1

CEO

Vikram Grover, CFA

Headquarters

Bellaire, TX 77401, US

BPTH Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

64%

Return on Assets

-9%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$383.00K

Shares Outstanding

9.34M

Volume

102.81K

Avg. Volume

24.70K

Financials (TTM)

Gross Profit

$96.00K

Operating Income

$8.33M

EBITDA

$8.24M

Operating Cash Flow

$1.60M

Capital Expenditure

$0.00

Free Cash Flow

$1.60M

Cash & ST Invst.

$0.00

Total Debt

$463.00K

Bio-Path Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$11.00K

+65.6%

Gross Margin

0.00%

N/A

Market Cap

$383.00K

N/A

Market Cap/Employee

$38.30K

N/A

Employees

10

N/A

Net Income

$270.00K

+90.5%

EBITDA

$297.00K

+89.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$499.00K

-158.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$511.00K

+62.2%

Return on Assets

-9.00%

N/A

Return on Invested Capital

63.58%

N/A

Free Cash Flow

$38.00K

+97.1%

Operating Cash Flow

$38.00K

+97.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HXBMHelix BioMedix, Inc.
$1.79+0.00%
YECOYulong Eco-Materials Limited
$0.01+0.00%
EMMAEmmaus Life Sciences, Inc.
$0.01+0.00%
PAIOFPaion AG
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$215.33-0.02%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About BPTH

What is the current price of Bio-Path?

Bio-Path is trading at $0.04 per share.

What is the 52-week range for Bio-Path?

Over the past 52 weeks, Bio-Path has traded between $0.01 and $0.23.

How much debt does Bio-Path have?

As of the most recent reporting period, Bio-Path reported total debt of $511,000.

How much cash does Bio-Path have on hand?

Bio-Path reported $12,000 in cash and cash equivalents in its most recent financial results.

What is Bio-Path’s dividend yield?

Bio-Path does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.